Jan. 31, 2019—Zhijun Yin and colleagues have found that breast cancer patients who message their doctors about certain topics are more likely to discontinue hormone therapy than others--which enables doctors to better predict which patients are at risk of stopping their treatment early.
Jan. 16, 2019—A team led by biomolecular engineer John Wilson and cancer biologist Rebecca Cook have found a way to trigger an immune response that targets breast cancer cells.
Jan. 10, 2019—A large-scale study conducted among East Asians and led by Vanderbilt researchers has identified multiple, previously unknown genetic risk factors for colorectal cancer.
Dec. 13, 2018—The grant will support Mary Philip's research to develop an organoid model — a miniature cell model of a functioning organ — of the liver to enable three-dimensional observation of immune-cancer interactions at the single-cell level at the earliest stages of cancer development.
Nov. 15, 2018—Pulmonary hypertension may be treated by targeting a bone marrow cell that normally promotes the growth of new blood vessels, according to new research by David Merryman.
Oct. 26, 2018—The grant will allow Charles Caskey to lead research into using ultrasound as an image-guided therapy for drug delivery.
Sep. 27, 2018—A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research program.
Sep. 27, 2018—A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.
Jun. 28, 2018—Vanderbilt (VU and VUMC collaboratively) may nominate one candidate for the Rita Allen Foundation Scholars Award Program for 2019. The foundation supports early-career biomedical scholars doing pioneering research. This award typically provides $550,000 over five yearsfor young investigators involved in research in the cure and treatment of diseases in the fields of cancer, immunology, and neuroscience.